SLC6A4 and drug-induced dyskinesia: In Parkinson’s disease, [11C]DASB PET studies have shown that aberrations of SERT in different brain areas are related to both motor and NMS, including tremor severity (6), dyskinesia (7), fatigue (8), and depressive symptoms (9).